Time to all-cause death or repeated revascularization shorter with off-pump versus on-pump coronary artery bypass grafting
THURSDAY, March 10, 2022 (HealthDay News) — Coronary artery bypass grafting (CABG) outcomes are similar at 10 years for veterans undergoing “on-pump” or “off-pump” procedures, according to a study published online Feb. 16 in JAMA Surgery.
Jacquelyn A. Quin, M.D., from the Veterans Affairs Boston Healthcare System in West Roxbury, Massachusetts, and colleagues evaluated the 10-year outcomes and costs of off-pump versus on-pump CABG. The analysis included 2,203 veterans randomly assigned to the off-pump group (1,104 patients) or the on-pump group (1,099 patients).
The researchers found that the 10-year death rates were 34.2 percent for the off-pump group and 31.1 percent for the on-pump group (relative risk, 1.05; 95 percent confidence interval, 0.99 to 1.11; P = 0.12). For the off-pump group, the median time to the composite end point (all-cause death or repeated revascularization) was 4.6 years, which was approximately 4.3 months shorter than that for the on-pump group (5.0 years). There were no significant 10-year treatment-related differences for any other primary or secondary end points.
“For veterans, in the absence of contraindications, the traditional on-pump CABG technique should not be supplanted by an off-pump CABG approach,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children
Addition of CAC to PREVENT-ASCVD Equations May Improve Predictive Utility in Certain Patients
All-Cause Mortality Elevated for Adult Five-Year Survivors of Hodgkin Lymphoma
Robotic Arm-Assisted TKR Offers Similar Outcome to Conventional TKR
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors
Safety Intervention Reduces Incidence of Postoperative Endophthalmitis
First Metatarsophalangeal Joint Arthrodesis Eases Painful Hallux Rigidus
Full, Limited Functional Endoscopic Sinus Surgery Beneficial in Rhinosinusitis With Nasal Polyps